Deepti Singh
Aligarh Muslim University
22 Papers
Deepti Singh is an academic researcher from Aligarh Muslim University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 6 publications.
Chat about Author
Papers
Apigenin in Cancer Prevention and Therapy: A Systematic Review and Meta-Analysis of Animal Models.
TL;DR: A total of 25 studies focused on the anticancer effects of Apigenin on various cancer types, including liver, prostate, pancreatic, lung, nasopharyngeal, skin, colon, colorectal, colitis-associated carcinoma, head and neck squamous cell carcinoma and breast cancer were included as mentioned in this paper .
54
Revisiting inorganic nanoparticles as promising therapeutic agents: A paradigm shift in oncological theranostics.
TL;DR: Inorganic nanoparticles (NPs) are considered promising agents in treating and tracing cancer due to their unique physicochemical properties such as the controlled release of drugs, bioavailability, biocompatibility, stability, and large surface area as discussed by the authors.
41
Apigenin, A Plant Flavone Playing Noble Roles in Cancer Prevention Via Modulation of Key Cell Signaling Networks.
TL;DR: This mini-review will explain the present research status of Apigenin and will further throw some light on howApigenin performs its anti-cancerous actions by interfering with the key cell-signaling pathways.
37
Accentuating CircRNA-miRNA-Transcription Factors Axis: A Conundrum in Cancer Research
TL;DR: The regulatory function of the circRNA-miRNA-TFs axis in the progression or suppression of cancer and the targeting of this axis as a potential therapeutic approach for cancer management are highlighted.
32
Apigenin alleviates cancer drug Sorafenib induced multiple toxic effects in Swiss albino mice via anti-oxidative stress.
TL;DR: In this article , the effects of Sorafenib-induced toxic effects at genomic, cellular, and tissue level and the potential protective effects of Apigenin were investigated, and it was shown that apigenin has protective effects against Sorafeni-induced toxicity and could be used to lessen its adverse effects and enhance its efficacy.
24